Account-creators
1,040
edits
Jensflorian (talk | contribs) (→Pituitary neuroendocrine tumor (PitNET): PIT1 lineage update) |
Jensflorian (talk | contribs) |
||
Line 89: | Line 89: | ||
=Specific entities= | =Specific entities= | ||
==Pituitary neuroendocrine tumor (PitNET)== | ==Pituitary neuroendocrine tumor (PitNET)== | ||
Old terminology '''Pituitary adenoma''' is depreceated | Old terminology '''Pituitary adenoma''' is depreceated. | ||
The WHO 2022 Classification of tumours of endocrine organs recoginizes following tumours:<ref>{{cite journal |vauthors=Asa SL, Mete O, Perry A, Osamura RY |title=Overview of the 2022 WHO Classification of Pituitary Tumors |journal=Endocr Pathol |volume=33 |issue=1 |pages=6–26 |date=March 2022 |pmid=35291028 |doi=10.1007/s12022-022-09703-7 |url=}}</ref> | |||
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | |||
! PitNET lineage | |||
! PitNET type | |||
! subtypes | |||
! Hormone secretion | |||
! Transcription factor | |||
|- | |||
| PIT1 | |||
| Somatotroph tumor | |||
| Densely and sparsely granulated tumor | |||
| GH, a-subunit+/-, CK+ | |||
| PIT1 | |||
|- | |||
| PIT1 | |||
| Lactotroph tumor | |||
| Densely and sparsely granulated tumor | |||
| PRL, CK-ve or weak | |||
| PIT1, [[Estrogen receptor|ER]] | |||
|- | |||
| PIT1 | |||
| Mammosomatotroph tumor | |||
| | |||
| GH, PRL (usu. less), CK perinuclear +ve | |||
| PIT1, [[Estrogen receptor|ER]] | |||
|- | |||
| PIT1 | |||
| Thyrotroph tumor | |||
| | |||
| TSH, CK-ve or weak | |||
| PIT1, GATA3 | |||
|- | |||
| PIT1 | |||
| Mature plurihormonal PIT1 lineage tumor | |||
| | |||
| GH, PRL, TSH, a-subunit +/-ve, CK perinuclear | |||
| PIT1, [[Estrogen receptor|ER]], GATA3 | |||
|- | |||
| PIT1 | |||
| Immature PIT1 lineage tumor | |||
| | |||
| Only focal GH, PRL, TSH, a-subunit +/-ve, CK variable | |||
| PIT1, [[Estrogen receptor|ER]] +/-ve, GATA3 +/-ve | |||
|- | |||
| PIT1 | |||
| Acidophilic stem cell tumor | |||
| | |||
| PRL, GH (focal/variable), CK fibrous bodies | |||
| PIT1, [[Estrogen receptor|ER]] | |||
|- | |||
| | |||
| Corticotroph adenoma | |||
| Densely and sparsely granulated adenoma, Crooke cell adenoma | |||
| ACTH,CAM 5.2 | |||
| TPIT | |||
|- | |||
| | |||
| Gonadotroph adenoma | |||
| Sparsely granulated adenoma | |||
| FSH, LH or a-Subunit | |||
| SF1, [[Estrogen receptor|ER]], GATA2 | |||
|- | |||
| | |||
| Null cell adenoma | |||
| | |||
| None | |||
| None | |||
|} | |||
Other tumours may be classified as plurhormonal or double adenomas or as adenomas with unusual IHC combination. | |||
===General=== | ===General=== | ||
*Clinical:<ref>{{Ref PBoD8|1100}}</ref> | *Clinical:<ref>{{Ref PBoD8|1100}}</ref> | ||
Line 152: | Line 225: | ||
*Smears very well.<ref>MUN. 24 November 2010.</ref> | *Smears very well.<ref>MUN. 24 November 2010.</ref> | ||